Tesla
Dividend Schedule
Stock Rankings
ETF Rankings
Crypto Rankings
See Graham's ranking
2.0
Solventum Corporation (SOLV) operates in the healthcare sector within the medical technology and healthcare solutions industry. The company was created through the spin-off of 3M’s healthcare division, focusing on the development of medical technologies, clinical products and healthcare management solutions.
Solventum develops and commercializes technologies used by hospitals, clinics, laboratories and healthcare professionals.
Its main areas of activity include:
• Medical devices and hospital products used in clinical procedures.
• Dental technologies and materials designed for professional dental practices.
• Infection prevention and sterilization solutions used in healthcare environments.
• Healthcare data and analytics platforms supporting clinical documentation and hospital management.
The company serves healthcare providers worldwide, offering solutions designed to improve operational efficiency, patient safety and clinical process management.
Solventum maintains an international presence, with operations primarily concentrated in North America, Europe and Asia, supported by research centers, manufacturing facilities and global distribution networks.
The medical technology industry in which Solventum operates is influenced by factors such as strict healthcare regulations, digital transformation in hospitals, advancements in medical devices and increasing demand for efficiency in healthcare systems.
Shares of Solventum Corporation trade on Nasdaq under the ticker SOLV.
History and Development
Solventum Corporation was established in 2024 in the United States following the spin-off of 3M’s healthcare division.
The separation was announced in 2022, aiming to allow the new company to operate independently and focus more directly on the development of healthcare technologies and medical solutions.
After the spin-off, the company structured its operations as an independent organization while maintaining the portfolio of technologies and products previously developed within 3M’s healthcare business.
In 2024, Solventum began trading on the Nasdaq, marking the start of its trajectory as an independent publicly traded healthcare technology company.
Since its creation, the company has continued investing in technological innovation, healthcare automation, clinical data analytics and the development of medical products designed to support the modernization of healthcare systems.
Additional Information
Solventum Corp. (United States) is listed on the Nasdaq and has a market capitalization of $13.73 billion, with shareholders equity totaling $4.97 billion.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Solventum Corp. reported $8.26 billion in revenue, generating net income of $1.43 billion.
Key financial metrics include a P/E ratio of 9.59, a price-to-book (P/B) ratio of 2.76, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker SOLV.
